中文
| Catalogue |
| Recommend Products |
Ubiquigent Limited.
United Kingdom, Manufacturer, Hits: 1591, Updated:8/16/2018
Sir James Black Centre,Dow Street,Dundee DD1 5EH,Scotland, UK |
Company Profile
-
Ubiquigent Limited is a specialist developer and supplier of Drug Discovery Services, high quality Research Tools and Chemistry to the life science research community worldwide.
Ubiquigent’s scientific and business interests have a clear focus; namely the ubiquitin, ubiquitin-like, and integrated signalling systems.
The Company has established its scientific and business credentials with both academic researchers undertaking fundamental scientific discovery and pharmaceutical and biotechnology company scientists exploring the potential of ubiquitin cascade-focused drug discovery.
Ubiquigent benefits from high calibre backing including from private US investors, the UK Medical Research Council, and the University of Dundee. The Company’s headquarters and laboratory operations are based in the UK and are located in a state-of-the-art facility adjacent to the MRC Protein Phosphorylation and Ubiquitylation Unit at the University of Dundee (both founded by Professor Sir Philip Cohen). In addition to Ubiquigent’s own facilities and capabilities, such proximity provides ready access to a huge range of additional scientific expertise (1,000+ life-science researchers on site), technological competencies, and assay and analytical platforms.
Ubiquigent staff have a wealth of scientific experience, technological competencies and commercial expertise, gained from within academia, the life science research reagents and services sector, and the pharmaceutical industry, that enables the Company to offer a level of understanding and service to its customers and clients worldwide that few companies may match.
Company News
- Ubiquigent Celebrates Milestone Anniversary of DUBprofiler™ Compound Profiling Platform 12/15/2021
- Ubiquigent Extends and Expands Drug Discovery Collaboration with Bristol Myers Squibb 10/27/2021
- Ubiquigent and the University of York Awarded a Grant to Explore the Potential of Deubiquitylase (... 1/18/2021
- 1/18/2021
- Ubiquigent Continues Drug Discovery Collaboration With Bristol Myers Squibb 6/18/2020
- Ubiquigent Announced the Launch of its New Service, DUBprofiler-Cell™ 1/31/2020
- Ubiquigent: Rapid Identification of Redox Cycling Compounds- REDOXprofiler™ 8/23/2018
- Ubiquigent Awarded Innovate UK Grant and Closes Further Round of Investment 8/16/2018